Recombinant MS4A1 (Obinutuzumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-MS4A1 (Obinutuzumab Biosimilar) antibody is suitable to detect MS4A1 (Obinutuzumab Biosimilar) in samples from Human. It has been validated for ELISA.
Catalog No. ABIN7487892
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant MS4A1 (Obinutuzumab Biosimilar) antibody (ABIN7487892)
Target
MS4A1 (Obinutuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This MS4A1 (Obinutuzumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Obinutuzumab Biosimilar - Anti-MS4A1, CD20 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- MS4A1 (Obinutuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
GA101,RG7159,RO5072759,afutuzumab
Obinutuzumab is a humanized monoclonal antibody that can be used in combination with chlorambucil to treat chronic lymphocytic leukemia. It was sold under the Gazyva brand. There are black box warnings of fatal hepatitis B virus (HBV) reactivation and fatal progressive multifocal leukoencephalopathy (PML). -
CAS-No
- 949142-50-1
Target
-
You are here:
